---
figid: PMC10888452__ijms-25-01973-g002
figtitle: PI3K/AKT/mTOR target drugs along the PI3K pathway in oncology
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10888452
filename: ijms-25-01973-g002.jpg
figlink: /pmc/articles/PMC10888452/figure/F2
number: F2
caption: Overview of PI3K/AKT/mTOR target drugs along the PI3K pathway in oncology.
  PI3K inhibitors can be subclassified into pan PI3K, isoform-specific inhibitors
  and dual PI3K/mTOR inhibitors. Isoform-specific PI3K inhibitors can be sub-classified
  into PI3Kβ, PI3Kδ, PI3Kα, and PI3Kδ inhibitors. Created with BioRender.com
papertitle: Molecular Targeting of the Phosphoinositide-3-Protein Kinase (PI3K) Pathway
  across Various Cancers
reftext: Khine S. Shan, et al. Int J Mol Sci. 2024 Feb;25(4).
year: '2024'
doi: 10.3390/ijms25041973
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: phosphatidylinositol-3-kinase | PI3K | AKT | mTOR | targeted therapy | molecular
  profiling | personalized medicine
automl_pathway: 0.9328783
figid_alias: PMC10888452__F2
figtype: Figure
redirect_from: /figures/PMC10888452__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10888452__ijms-25-01973-g002.html
  '@type': Dataset
  description: Overview of PI3K/AKT/mTOR target drugs along the PI3K pathway in oncology.
    PI3K inhibitors can be subclassified into pan PI3K, isoform-specific inhibitors
    and dual PI3K/mTOR inhibitors. Isoform-specific PI3K inhibitors can be sub-classified
    into PI3Kβ, PI3Kδ, PI3Kα, and PI3Kδ inhibitors. Created with BioRender.com
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3R1
  - PIK3R2
  - ARHGEF7
  - CBFA2T2
  - PPP1R13B
  - PPP1R12C
  - KRAS
  - HRAS
  - NRAS
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - PIK3CA
  - CUX1
  - SART3
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - ADA2
  - PTEN
  - PDK1
  - PDPK1
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - RPTOR
  - CSNK1E
  - RAS
  - PIP3
  - Copanlisib
  - MTOR Inhibitors
  - Everolimus
---
